How Much Does Smoking Raise Blood Sugar?

Smoking raises blood sugar both immediately and over the long term, and the effect is driven almost entirely by nicotine. A single cigarette can push blood glucose upward within minutes, and years of smoking progressively erode the body’s ability to respond to insulin. The size of the spike after one cigarette is modest on its own, but the cumulative damage to glucose regulation is substantial enough that current smokers with diabetes consistently have worse blood sugar control than non-smokers, even when following similar treatment plans.

The Immediate Spike After a Cigarette

When you light up and inhale, your blood glucose starts climbing almost right away. Research comparing smokers with and without diabetes found that both groups showed a rise in blood sugar after smoking, though the increase was more pronounced in people with diabetes.¹ That same study ran a telling control experiment: when subjects smoked nicotine-free cigarettes or smoked regular tobacco without inhaling, blood sugar didn’t budge. The rise happens because of nicotine, not the act of smoking itself or other chemicals in the smoke.

And the effect stacks. When participants smoked a second cigarette shortly after the first, the glucose rise was even higher than the first time around, suggesting that each additional dose of nicotine compounds the problem within a single session.¹ For someone who chain-smokes several cigarettes in an hour, the acute blood sugar impact could be meaningfully higher than from a single cigarette.

Why Nicotine Pushes Blood Sugar Up

Nicotine disrupts blood sugar through multiple pathways working at the same time, which is why the effect is so consistent across studies. The broadest way to think about it: nicotine makes your cells less responsive to insulin, the hormone that moves sugar out of your blood and into your tissues for energy. Research in both animals and humans has confirmed that nicotine elevates blood glucose, disrupts normal glucose balance, and directly induces insulin resistance.²

One well-studied mechanism involves what happens in skeletal muscle, which is where your body burns the majority of its glucose. In lab experiments on human muscle cells, nicotine exposure triggered a specific molecular change that made those cells resist insulin’s signal. Blocking a particular cellular pathway (called mTOR) during nicotine exposure prevented this resistance from developing, while blocking a different pathway did not.² This finding matters practically because it means the insulin resistance from nicotine is mechanistically specific, not just a vague side effect of general toxicity.

Beyond the insulin resistance at the cellular level, nicotine also impairs your body’s ability to clear glucose from the bloodstream by reducing how much sugar your peripheral tissues absorb. One study using a technique to directly measure insulin action found that smoking reduced peripheral glucose uptake, confirming that the problem is partly about your muscles and fat tissue simply not pulling sugar in fast enough.³ That same study found that growth hormone levels more than doubled during smoking sessions, which is relevant because growth hormone counteracts insulin.

The Stress Hormone Surge

Each cigarette triggers a small burst of stress hormones, and this turns out to be another route through which smoking raises blood sugar. Cortisol, the body’s primary stress hormone, is one of several hormones that tells your liver to release stored glucose into the bloodstream. After smoking a high-nicotine cigarette, cortisol levels rise significantly within about 20 minutes and peak around an hour later.⁴ ACTH, the pituitary hormone that stimulates cortisol release, climbs even faster, rising within about 12 minutes of the first puff.⁴

This isn’t just a momentary blip. Habitual smokers carry higher cortisol levels throughout the entire day, not only right after a cigarette. A large study measuring salivary cortisol on both working and weekend days found that smokers had significantly higher cortisol levels than non-smokers after adjusting for age, sex, and employment grade.⁵ Another study quantified the difference: smokers released roughly 12% more cortisol per hour across the day compared to people who had never smoked.⁶ That chronic cortisol elevation keeps nudging the liver to dump glucose, which over time contributes to persistently higher blood sugar.

Chronic Inflammation Adds to the Damage

Beyond the acute hormonal effects, long-term smoking creates a state of ongoing low-grade inflammation that further undermines blood sugar control. Tobacco smoke damages the immune system and triggers excessive production of inflammatory signaling molecules. The body’s antioxidant defenses often can’t keep up with the flood of reactive oxygen species generated by cigarette smoke, leading to oxidative stress that activates immune cells and perpetuates a cycle of inflammation.⁷ This chronic inflammatory state directly interferes with insulin signaling in tissues throughout the body, layering on top of the more immediate effects of nicotine.

Smoking is recognized as a genuine risk factor for developing type 2 diabetes, though researchers note it remains poorly understood compared to more traditional risk factors like obesity and physical inactivity.⁸ The risk appears to be similar for men and women. What makes smoking’s role tricky to study is that it interacts with so many other metabolic pathways simultaneously: insulin resistance, inflammation, cortisol, fat distribution, and oxidative stress all running in parallel.

How Smoking Undermines Diabetes Management

For people who already have diabetes, the practical question is whether smoking makes it measurably harder to manage blood sugar. The answer is a clear yes. A large study of Chinese adults with diabetes found that current smokers had roughly 50% higher odds of having poor blood sugar control, defined as an HbA1c of 7% or above. The odds were elevated in both men and women.⁹

A matched cohort study of men with newly diagnosed type 2 diabetes tracked HbA1c over a full year. Both smokers and non-smokers saw their blood sugar improve with treatment, but smokers consistently lagged behind. At 12 months, non-smokers had reduced their HbA1c by about 2.68 percentage points, while smokers achieved a reduction of only 2.38 points, a gap of about 0.30%.¹⁰ That difference might sound small in isolation, but for someone trying to get their HbA1c below a target threshold, it can be the margin between controlled and uncontrolled diabetes. The largest gap, roughly 0.33%, appeared at just three months, suggesting smoking’s interference kicks in early and persists.¹⁰

In practical terms, if you smoke and have diabetes, your medications and dietary efforts are working against a headwind. The insulin resistance, the cortisol-driven glucose dumps from the liver, and the inflammatory drag on your metabolism all blunt the effectiveness of the same treatments that work better in non-smokers.

What Happens to Blood Sugar When You Quit

Quitting smoking improves insulin sensitivity over time, but the road isn’t perfectly smooth. A scoping review of the evidence found that insulin resistance, measured by a standard lab marker called HOMA-IR, decreased in former smokers over time compared to people who kept smoking.¹¹ That improvement held even though quitters gained a small but statistically significant amount of weight, which would normally push insulin resistance in the opposite direction.

The catch is the short-term picture. In the first few months to three years after quitting, many people experience a temporary worsening of glucose tolerance, driven largely by weight gain.¹² This is paradoxical: quitting removes the direct toxic effects of nicotine on insulin signaling, but the weight gain that commonly follows can independently raise blood sugar and even temporarily increase the risk of developing type 2 diabetes in some cases.¹³ The people at highest risk for this rebound are those who gain the most weight after quitting.

This doesn’t mean quitting is bad for blood sugar. The long-term trajectory favors quitting decisively. But if you have diabetes or prediabetes and you’re planning to stop smoking, it’s worth being aware that your blood sugar readings may temporarily get worse before they get better, and proactive management of weight during that transition period can make a real difference.

Nicotine Replacement, E-Cigarettes, and the Nicotine Problem

A common question is whether switching to nicotine gum, patches, or e-cigarettes avoids the blood sugar effects. The answer is mostly no, because nicotine itself is the main driver. A study of long-term nicotine gum users found that they developed insulin resistance and elevated insulin levels, and the degree of insulin resistance correlated with how much nicotine they were consuming, measured by a nicotine metabolite in their blood.¹⁴ The researchers concluded that nicotine, rather than the other thousands of chemicals in cigarette smoke, is the major component driving insulin resistance.

E-cigarette research is still in its early stages, and most of the data comes from animal studies. One mouse study found that e-cigarette vapor containing nicotine actually improved glucose tolerance in obese mice, while nicotine-free vapor did not have the same effect.¹⁵ That result seems to contradict the human nicotine gum data and highlights how limited the e-cigarette evidence is. Mice metabolize nicotine differently, they were on specific experimental diets, and the exposure patterns bear little resemblance to how a person actually vapes. Drawing firm conclusions about e-cigarettes and blood sugar in humans would be premature.

The practical takeaway is that if you’re using nicotine replacement products as a bridge to quitting entirely, the temporary nicotine exposure is almost certainly preferable to continuing to smoke, because cigarettes deliver nicotine alongside carbon monoxide, particulate matter, and thousands of other compounds that compound cardiovascular and metabolic damage. But staying on nicotine indefinitely, whether from gum or vaping, likely perpetuates some degree of insulin resistance.

Secondhand Smoke and Metabolic Effects

You don’t have to smoke to be affected. A large Korean study of over 118,000 never-smokers examined whether secondhand smoke exposure was associated with metabolic syndrome, a cluster of conditions that includes elevated blood sugar. Among women, regular secondhand smoke exposure of an hour or more per day was linked to about a 22% increase in the odds of metabolic syndrome.¹⁶ Women exposed three or more times had about 30% higher odds.¹⁶ Interestingly, the association was not significant for men in that study, which may reflect differences in how secondhand smoke interacts with hormonal metabolism across sexes, or it could be a statistical artifact of the study population.

The mechanism is plausible: secondhand smoke delivers nicotine and other combustion products, just at lower doses. If direct smoking raises blood sugar through nicotine-driven insulin resistance and cortisol surges, passive inhalation of the same chemicals should produce a smaller version of the same effect. For people who live or work with heavy smokers and are already at risk for diabetes, this is worth knowing about.

Smoking, Belly Fat, and a Feedback Loop

One often-overlooked way smoking worsens blood sugar control is through its effect on body fat distribution. Smokers tend to be leaner overall than non-smokers, which creates a misleading impression that smoking is metabolically protective. In reality, smoking shifts fat toward the abdomen and visceral organs, exactly the kind of fat most strongly linked to insulin resistance and metabolic disease. A study of Japanese men found that greater lifetime smoking was associated with a higher waist-to-hip ratio and more visceral fat relative to subcutaneous fat, even after adjusting for overall body mass.¹⁷

This creates a feedback loop. Nicotine promotes insulin resistance through the direct mechanisms described earlier. Insulin resistance promotes visceral fat accumulation. Visceral fat produces inflammatory molecules that further worsen insulin resistance. And the whole cycle keeps blood sugar elevated even as the smoker’s bathroom scale might read a relatively normal weight. It’s one reason why smoking’s effects on blood sugar are easy to underestimate if you only look at someone’s BMI.

Genetic Variation in How Smoking Affects Blood Sugar

Not everyone’s blood sugar responds to smoking identically, and emerging research suggests that genetics play a role in who gets hit hardest. A genome-wide interaction study looked at how smoking interacts with specific gene variants to influence insulin sensitivity and resistance in people who still had normal glucose tolerance. The study identified several genetic locations where the effect of smoking on insulin resistance flipped depending on which version of the gene a person carried. At one location, smoking was associated with increased insulin resistance in people with one genotype, while the opposite effect appeared in people with a different genotype at the same spot.¹⁸

This research is still very early, and no one is running genetic panels to decide whether smoking is “safe” for certain genotypes. It’s not. But the finding helps explain why some heavy smokers never develop diabetes while others develop insulin resistance relatively quickly. The underlying genetic landscape modifies how severely nicotine disrupts your metabolic machinery. It also hints at why population-level studies sometimes produce messy results when they don’t account for genetic diversity in their cohorts.

The Cortisol Rebound After Quitting

One detail that gets little attention is what happens to cortisol levels after someone quits smoking. The same study that found smokers have higher cortisol throughout the day also found that former smokers had cortisol levels statistically indistinguishable from people who had never smoked.⁶ The mean hourly cortisol release for ex-smokers was 4.21 nanomoles per liter, compared to 4.13 for never-smokers and 4.63 for current smokers. The difference between ex-smokers and never-smokers was not statistically significant.

This is encouraging because it suggests the cortisol-mediated pathway, where the stress hormone constantly signals the liver to release glucose, actually normalizes after quitting. The body doesn’t remain stuck in a permanently elevated cortisol state. Combined with the evidence that insulin resistance also improves over time in former smokers, the metabolic case for quitting is strong even though the short-term weight gain complicates the picture. The cortisol pathway, at least, appears to reset relatively cleanly.

1
PubMed. Effect of cigarette smoking on the blood glucose level in normals and diabetics
2
PubMed Central. Novel and reversible mechanisms of smoking-induced insulin resistance in humans
3
PubMed. Smoking induces insulin resistance–a potential link with the insulin resistance syndrome – Section: RESULTS
4
PubMed Central. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men
5
PubMed. Smoking, cortisol and nicotine
6
The Journal of Clinical Endocrinology & Metabolism. The Relationship between Smoking Status and Cortisol Secretion
7
PubMed. Chronic Tobacco Exposure by Smoking Develops Insulin Resistance
8
PubMed. Smoking and diabetes
9
PubMed. Association between smoking and glycemic control in diabetic patients: Results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study
10
PubMed Central. Association between smoking and glycemic control in men with newly diagnosed type 2 diabetes: a retrospective matched cohort study
11
PubMed Central. Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review – Section: SMOKING CESSATION AND INSULIN RESISTANCE AND INSULIN SECRETION
12
Clin Med Rev Case Rep. Abrupt Increase in Glucose Intolerance after Smoking Cessation Therapy: A Case Report
13
PubMed Central. The effect of tobacco cessation on weight gain, obesity and diabetes risk
14
PubMed. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance
15
PubMed Central. Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
16
PubMed Central. Association between Secondhand Smoke Exposure and Metabolic Syndrome in 118,609 Korean Never Smokers Verified by Self-Reported Questionnaire and Urine Cotinine
17
PubMed Central. Lifetime cigarette smoking is associated with abdominal obesity in a community-based sample of Japanese men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA)
18
PubMed Central. Gene‐Smoking Interaction in Insulin Sensitivity and β‐Cell Function Among Normal Glucose Tolerance Individuals